280 related articles for article (PubMed ID: 28089934)
1. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
[TBL] [Abstract][Full Text] [Related]
2. Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation.
Zheng S; Puri A; Li J; Jaiswal A; Adams M
AAPS J; 2017 Jan; 19(1):110-116. PubMed ID: 27620008
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
4. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
[TBL] [Abstract][Full Text] [Related]
5. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
[TBL] [Abstract][Full Text] [Related]
6. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
[TBL] [Abstract][Full Text] [Related]
8. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.
Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF
J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229
[TBL] [Abstract][Full Text] [Related]
9. Albinterferon α2b adsorption to silicone oil-water interfaces: effects on protein conformation, aggregation, and subvisible particle formation.
Basu P; Blake-Haskins AW; O'Berry KB; Randolph TW; Carpenter JF
J Pharm Sci; 2014 Feb; 103(2):427-36. PubMed ID: 24382812
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
[TBL] [Abstract][Full Text] [Related]
13. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
14. Protein aggregation and particle formation in prefilled glass syringes.
Gerhardt A; Mcgraw NR; Schwartz DK; Bee JS; Carpenter JF; Randolph TW
J Pharm Sci; 2014 Jun; 103(6):1601-12. PubMed ID: 24729310
[TBL] [Abstract][Full Text] [Related]
15. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
Patel AR; Lau D; Liu J
Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
[TBL] [Abstract][Full Text] [Related]
16. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
[TBL] [Abstract][Full Text] [Related]
17. Micro-flow imaging and resonant mass measurement (Archimedes)--complementary methods to quantitatively differentiate protein particles and silicone oil droplets.
Weinbuch D; Zölls S; Wiggenhorn M; Friess W; Winter G; Jiskoot W; Hawe A
J Pharm Sci; 2013 Jul; 102(7):2152-65. PubMed ID: 23625851
[TBL] [Abstract][Full Text] [Related]
18. Silicone Migration From Baked-on Silicone Layers. Particle Characterization in Placebo and Protein Solutions.
Funke S; Matilainen J; Nalenz H; Bechtold-Peters K; Mahler HC; Friess W
J Pharm Sci; 2016 Dec; 105(12):3520-3531. PubMed ID: 27773525
[TBL] [Abstract][Full Text] [Related]
19. Introducing the Alba
Chillon A; Pace A; Zuccato D
PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
[TBL] [Abstract][Full Text] [Related]
20. Friability Testing as a New Stress-Stability Assay for Biopharmaceuticals.
Torisu T; Maruno T; Yoneda S; Hamaji Y; Honda S; Ohkubo T; Uchiyama S
J Pharm Sci; 2017 Oct; 106(10):2966-2978. PubMed ID: 28603019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
